NCT06223139Completed
Association Between Handgrip Strength and Small Airway Disease in Patients with Stable Chronic Obstructive Pulmonary Disease
Source: ClinicalTrials.gov · Last updated 17 Jan 2025
Brief summary (registry, in English)
The goal of this observational study is to investigate the correlation between handgrip strength and small airway disease among patients with chronic obstructive pulmonary disease (COPD). The main question it aims to answer is: • Is handgrip strength correlated with small airway disease in COPD patients? Participants will perform handgrip strength test and impulse oscillometry (IOS).
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 64 (actual)
- First submitted
- 12 Jan 2024
- Start date
- 1 Mar 2023
- Primary completion date
- 31 Jan 2024
- Lead sponsor
- Thammasat University
- Diseases
- COPD
- NCT number
- NCT06223139
What you commit to
- Study type: Observational
- Participants enrolled: 64
- From 1 Mar 2023 to the primary completion date, 31 Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- COPD exacerbation within 3 months
- Inability to perform handgrip strength test or impulse oscillometry
Who the study is looking for
- COPD patients aged 40 years or older
- Confirmed diagnosis by spirometry (post-bronchodilator FEV1/FVC \<0.7)
- Smoking history 10 pack-years or more
Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Thammasat University Faculty of Medicine Coordinator of this site? Confirm its status | Pathum Thani | Thailand | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.